The Canadian Institutes of Health Research (CIHR) and Diabetes Canada supported this work (ARJ-162628, Project Grant 156136 and New Investigator award to EEM and Project Grant 148634 and New Investigator award 141981 to MDF)
Across nine publications, treatment was associated with improvements in disease activity, flares, pain, and quality of life often alongside weight loss and metabolic improvement
This designation allows use strictly for in vitro testing and laboratory experimentation
At each new dose level, nausea may return briefly before your body adjusts again
Zimmerman, M., Gottster, A
Facial fat serves a protective function and affects facial aesthetics and elasticity